IL1B and neurodegenerative disease: Since the inflammasome is able to mediate the release of IL-1β and IL-18, which can trigger a cascade of secondary inflammatory events in neuroinflammation, this multiprotein complex is a critical mediator of neuroinflammation and a potential therapeutic target in the treatment of several neurodegenerative diseases.